Table 3 Correlation between serum levels of tumor necrosis factor (TNF-α) and nerve conduction velocity, clinical, and lab. data in type 2 diabetes mellitus
From: Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus
Serum level (TNF-α) | ||||
|---|---|---|---|---|
Group 1 | Group 2 | |||
R | P value | R | P value | |
Median nerve (M) | − 0.35 | 0.008 | − 0.650 | < 0.001 |
Ulnar nerve | − 0.51 | 0.001 | − 0.46 | 0.002 |
CPN nerve | − 0.23 | 0.03 | − 0.25 | 0.02 |
PTN nerve | − 0.20 | 0.04 | − 0.21 | 0.04 |
Median nerve(S) | − 0.26 | 0.01 | − 0.36 | 0.007 |
Sural nerve | − 0.33 | 0.004 | − 0.22 | 0.03 |
Neuropathy disability score | 0.829 | < 0.001 | 0.50 | 0.001 |
Neuropathy symptom score | 0.53 | < 0.001 | 0.38 | 0.004 |
HbA1c | 0.45 | 0.002 | 0.41 | 0.005 |